+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chronic Bronchitis Drug"

Chronic Bronchitis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Chronic Bronchitis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Chronic Bronchitis Drugs are medications used to treat chronic bronchitis, a condition characterized by inflammation and narrowing of the airways. These drugs are typically prescribed to reduce inflammation, improve airway function, and reduce the frequency and severity of symptoms. Commonly prescribed drugs include bronchodilators, corticosteroids, and antibiotics. Bronchodilators are used to relax the airways and improve airflow, while corticosteroids reduce inflammation and help prevent further damage to the airways. Antibiotics are used to treat bacterial infections that can worsen bronchitis symptoms. Some companies in the Chronic Bronchitis Drug market include GlaxoSmithKline, AstraZeneca, Merck, Pfizer, and Novartis. Show Less Read more